HOME › DRUGS › IRBESARTAN;HYDROCHLOROTHIAZIDE
ACTIVE SUBSTANCE / INN

IRBESARTAN;HYDROCHLOROTHIAZIDE

Brand name(s): Irbesartan Hydrochlorothiazide BMS, Karvezide, Irbesartan/Hydrochlorothiazide Teva, Ifirmacombi, CoAprovel, Irbesartan Hydrochlorothiazide Zentiva (previously Irbesartan Hydrochlorothiazide Winthrop)
EMA LISTED
WITHDRAWN
AUTHORISED
Hypertension
ACTIVE SUBSTANCE
Irbesartan;Hydrochlorothiazide
REGULATORS
EMA
SPONSORS / MAH
sanofi-aventis groupe , Sanofi Winthrop Industrie, Krka, d.d., Novo mesto
TOTAL APPLICATIONS
6
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
Irbesartan Hydrochlorothiazide Zentiva (previously Irbesartan Hydrochlorothiazide Winthrop)sanofi-aventis groupe Authorised18/01/2007Hypertension
IfirmacombiKrka, d.d., Novo mestoAuthorised04/03/2011Hypertension
Irbesartan/Hydrochlorothiazide TevaTeva B.V. Authorised26/11/2009Hypertension
KarvezideSanofi Winthrop IndustrieAuthorised16/10/1998Hypertension
CoAprovelSanofi Winthrop IndustrieAuthorised14/10/1998Hypertension
Irbesartan Hydrochlorothiazide BMSBristol-Myers Squibb Pharma EEIGWithdrawn19/01/2007Hypertension

FULL INTELLIGENCE ON IRBESARTAN;HYDROCHLOROTHIAZIDE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →